294 related articles for article (PubMed ID: 33950341)
21. Multimodal treatment of parasagittal meningiomas: a single-center experience.
Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
[TBL] [Abstract][Full Text] [Related]
22. Molecular and translational advances in meningiomas.
Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
[TBL] [Abstract][Full Text] [Related]
23. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and management differences for grade II and III spinal meningiomas.
Krauss WE; Yolcu YU; Alvi MA; Moinuddin FM; Goyal A; Clarke MJ; Marsh WR; Bydon M
J Neurooncol; 2021 Jun; 153(2):313-320. PubMed ID: 33973145
[TBL] [Abstract][Full Text] [Related]
25. Malignant meningiomas.
Fountain DM; Young AMH; Santarius T
Handb Clin Neurol; 2020; 170():245-250. PubMed ID: 32586496
[TBL] [Abstract][Full Text] [Related]
26. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
27. Atypical meningiomas.
Chen R; Aghi MK
Handb Clin Neurol; 2020; 170():233-244. PubMed ID: 32586495
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Kaur G; Sayegh ET; Larson A; Bloch O; Madden M; Sun MZ; Barani IJ; James CD; Parsa AT
Neuro Oncol; 2014 May; 16(5):628-36. PubMed ID: 24696499
[TBL] [Abstract][Full Text] [Related]
29. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
[TBL] [Abstract][Full Text] [Related]
30. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sun SQ; Hawasli AH; Huang J; Chicoine MR; Kim AH
Neurosurg Focus; 2015 Mar; 38(3):E3. PubMed ID: 25727225
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
Yew A; Trang A; Nagasawa DT; Spasic M; Choy W; Garcia HM; Yang I
J Clin Neurosci; 2013 Jan; 20(1):17-22. PubMed ID: 22743042
[TBL] [Abstract][Full Text] [Related]
33. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
34. Malignant Meningioma: An International Multicentre Retrospective Study.
Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
[TBL] [Abstract][Full Text] [Related]
35. A review of malignant meningiomas: diagnosis, characteristics, and treatment.
Hanft S; Canoll P; Bruce JN
J Neurooncol; 2010 Sep; 99(3):433-43. PubMed ID: 20730473
[TBL] [Abstract][Full Text] [Related]
36. Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management.
Wilson TA; Huang L; Ramanathan D; Lopez-Gonzalez M; Pillai P; De Los Reyes K; Kumal M; Boling W
Front Oncol; 2020; 10():565582. PubMed ID: 33330036
[TBL] [Abstract][Full Text] [Related]
37. Management of Atypical and Anaplastic Meningiomas.
Higgins D; Shah AH; Komotar RJ; Ivan ME
Neurosurg Clin N Am; 2023 Jul; 34(3):437-446. PubMed ID: 37210132
[TBL] [Abstract][Full Text] [Related]
38. The role of radiotherapy in the management of high-grade meningiomas.
Hwang KL; Hwang WL; Bussière MR; Shih HA
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
[TBL] [Abstract][Full Text] [Related]
39. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
